EFG Asset Management’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.81M | Buy |
169,532
+14,112
| +9% | +$401K | 0.68% | 51 |
|
|
2025
Q1 | $4.59M | Buy |
155,420
+35,917
| +30% | +$1.06M | 0.76% | 32 |
|
|
2024
Q4 | $3.48M | Buy |
119,503
+58,198
| +95% | +$1.69M | 0.47% | 80 |
|
|
2024
Q3 | $2.81M | Buy |
61,305
+31,313
| +104% | +$1.44M | 0.47% | 82 |
|
|
2024
Q2 | $1.23M | Buy |
+29,992
| New | +$1.23M | 0.21% | 169 |
|